Pharmasset Inc

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$316.9M

617 transactions

Summary

Pharmasset Inc is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $15.1MSales: $79.0M45 insiders

Date	Insider	Type	Value
2012-01-12	OTTO MICHAEL J.(Chief Scientific Officer)	U	$2.0M
2012-01-12	Rogers Michael D.(Chief Development Officer)	D	$0
2012-01-12	Rogers Michael D.(Chief Development Officer)	D	$0
2012-01-12	Rogers Michael D.(Chief Development Officer)	D	$0
2012-01-12	Rogers Michael D.(Chief Development Officer)	D	$0
2012-01-12	OTTO MICHAEL J.(Chief Scientific Officer)	D	$0
2012-01-12	OTTO MICHAEL J.(Chief Scientific Officer)	D	$0
2012-01-12	OTTO MICHAEL J.(Chief Scientific Officer)	D	$0
2012-01-12	OTTO MICHAEL J.(Chief Scientific Officer)	D	$0
2012-01-12	OTTO MICHAEL J.(Chief Scientific Officer)	D	$0
2012-01-12	OTTO MICHAEL J.(Chief Scientific Officer)	D	$0
2012-01-12	OTTO MICHAEL J.(Chief Scientific Officer)	D	$0
2012-01-12	Price P Schaefer(President and CEO)	D	$0
2012-01-12	Price P Schaefer(President and CEO)	D	$0
2012-01-12	Price P Schaefer(President and CEO)	D	$0
2012-01-12	Price P Schaefer(President and CEO)	D	$0
2012-01-12	Price P Schaefer(President and CEO)	D	$0
2012-01-12	Price P Schaefer(President and CEO)	D	$0
2012-01-12	Price P Schaefer(President and CEO)	D	$0
2012-01-12	Price P Schaefer(President and CEO)	D	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Pharmasset Inc — Contributions, Lobbying & Contracts | Poliscope